- recruitingPHASE2
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
This study is looking at a new combination treatment for people with severe liver disease (cirrhosis) who have recently been in hospital. We want to see if combining two existing medicines, albumin and enoxaparin, is safe and helps improve outcomes after leaving the hospital.
France · Germany · Italy - recruiting
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
This study looks for new ways to predict how well people with severe liver cirrhosis will recover after a hospital stay. Researchers are using body markers to better understand the disease and help doctors give more personalised care to improve patient outcomes.
France · Germany · Italy